A preliminary cost-effectiveness analysis of hepatitis E vaccination among pregnant women in epidemic regions

Reference

• Bru JP. Forgotten hepatitis: the hepatitis E. Rev Med Suisse 2012; 8:986-8; PMID:22662626
   PubMedGoogle Scholar
• Freshwater DA, Hepatitis E. the forgotten virus. J R Army Med Corps 2013; 159:167-8; PMID:24109137; http://dx.doi.org/10.1136/jramc-2013-000095
   PubMed Web of Science ®Google Scholar
• Aggarwal R. Clinical presentation of hepatitis. E. Virus Res 2011; 161:15-22; http://dx.doi.org/10.1016/j.virusres.2011.03.017
   PubMed Web of Science ®Google Scholar
• Perez-Gracia MT, Suay B, Mateos-Lindemann ML. Hepatitis E: an emerging disease. Infect Genet Evol 2014; 22:40-59; PMID:24434240; http://dx.doi.org/10.1016/j.meegid.2014.01.002
   PubMed Web of Science ®Google Scholar
• Rein DB, Wiersma S, Stevens GA. Modeling the global burden of hepatitis E virus infection and disease in 2005. Hepatology 2011; 54:1176A
   Web of Science ®Google Scholar
• Gou AL, Wu LY, Ma XZ, Zhou YC, Ai NW, Mi JT, et al. An epidemiologic survey on a type E hepatitis (HE) outbreak in pregancy. Chin J Public Health 1989; 5:5-6.
   Google Scholar
• Shinde N, Patil T, Deshpande A, Gulhane R, Patil M, Bansod Y. Clinical profile, maternal and fetal outcomes of acute hepatitis E in pregnancy. Ann Med Health Sci Res 2014; 4:S133-9; PMID:25184080; http://dx.doi.org/10.4103/2141-9248.138033
   PubMedGoogle Scholar
• Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet 1995;345:1025-6; PMID:7723501; http://dx.doi.org/10.1016/S0140-6736(95)90761-0
   PubMed Web of Science ®Google Scholar
• Singh S, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 2003;70:37-9; PMID:12619951; http://dx.doi.org/10.1007/BF02722743
   PubMedGoogle Scholar
• Khuroo MS, Kamili S, Khuroo MS. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J Viral Hepat 2009;16:519-23; PMID:19228284; http://dx.doi.org/10.1111/j.1365-2893.2009.01101.x
   PubMed Web of Science ®Google Scholar
• Teshale E, Ward JW. Making hepatitis E a vaccine-preventable disease. N Engl J Med 2015; 372:899-901; PMID:25738664; http://dx.doi.org/10.1056/NEJMp1415240
   PubMed Web of Science ®Google Scholar
• Safary A. Perspectives of vaccination against hepatitis E. Intervirology 2001; 44:162-6; PMID:11509877; http://dx.doi.org/10.1159/000050043
   PubMed Web of Science ®Google Scholar
• Shrestha MP, Scott RM, Joshi DM, Mammen MP, Thapa GB, Thapa N, Myint KS, Fourneau M, Kuschner RA, Shrestha SK, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356:895-903; PMID:17329696; http://dx.doi.org/10.1056/NEJMoa061847
   PubMed Web of Science ®Google Scholar
• Emerson SU, Purcell RH. Recombinant vaccines for hepatitis E. Trends Mol Med 2001; 7:462-6; PMID:11597521; http://dx.doi.org/10.1016/S1471-4914(01)02106-2
   PubMed Web of Science ®Google Scholar
• Hepatitis E vaccine: why wait? Lancet 2010; 376:845; PMID:20833284; http://dx.doi.org/10.1016/S0140-6736(10)61393-1
   PubMed Web of Science ®Google Scholar
• Xia NS, Zhang J, Li SW, Ge SX, Wu T, Zheng ZZ, et al. Study Progress no Hepatitis E. J Xiamen Univ (Natural Science) 2011; 50:431-6.
   Google Scholar
• Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376:895-902; PMID:20728932; http://dx.doi.org/10.1016/S0140-6736(10)61030-6
   PubMed Web of Science ®Google Scholar
• Li SW, Zhao Q, Wu T, Chen S, Zhang J, Xia NS. The development of a recombinant hepatitis E vaccine HEV 239. Hum Vaccin Immunother 2015; 11:908-14; PMID:25714510; http://dx.doi.org/10.1080/21645515.2015.1008870
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang XF, Huang SJ, Wu T, Hu YM, Wang ZZ, Wang H, Jiang HM, Wang YJ, Yan Q, et al. Long-term efficacy of a hepatitis E vaccine. N Engl J Med 2015; 372:914-22; PMID:25738667; http://dx.doi.org/10.1056/NEJMoa1406011
   PubMed Web of Science ®Google Scholar
• Wu T, Zhu FC, Huang SJ, Zhang XF, Wang ZZ, Zhang J, Xia NS. Safety of the hepatitis E vaccine for pregnant women: a preliminary analysis. Hepatology 2012; 55:2038; PMID:22161542; http://dx.doi.org/10.1002/hep.25522
   PubMed Web of Science ®Google Scholar
• Blommaert A, Bilcke J, Vandendijck Y, Hanquet G, Hens N, Beutels P. Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium. Vaccine 2014; 32:6075-83; PMID:25239481; http://dx.doi.org/10.1016/j.vaccine.2014.08.085
   PubMed Web of Science ®Google Scholar
• Jit M, Cromer D, Baguelin M, Stowe J, Andrews N, Miller E. The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales. Vaccine 2010; 29:115-22; PMID:21055501; http://dx.doi.org/10.1016/j.vaccine.2010.08.078
   PubMed Web of Science ®Google Scholar
• Swamy GK, Garcia-Putnam R. Vaccine-Preventable Diseases in Pregnancy. Am J Perinatol 2013; 30:89-97; PMID:23271378
   PubMed Web of Science ®Google Scholar
• Beigi RH, Wiringa AE, Bailey RR, Assi TM, Lee BY. Economic value of seasonal and pandemic influenza vaccination during pregnancy. Clin Infect Dis 2009; 49:1784-92; PMID:19911967; http://dx.doi.org/10.1086/649013
   PubMed Web of Science ®Google Scholar
• Kim SY, Russell LB, Park J, Verani JR, Madhi SA, Cutland CL, Schrag SJ, Sinha A. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa. Vaccine 2014; 32:1954-63; PMID:24530145; http://dx.doi.org/10.1016/j.vaccine.2014.01.062
   PubMed Web of Science ®Google Scholar
• Roberts S, Hollier LM, Sheffield J, Laibl V, Wendel GD. Cost-effectiveness of universal influenza vaccination in a pregnant population. Obstet Gynecol 2006; 107:1323-9; PMID:16738159; http://dx.doi.org/10.1097/01.AOG.0000210225.45986.99
   PubMed Web of Science ®Google Scholar
• Khuroo MS. Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res 2011; 161:3-14; PMID:21320558; http://dx.doi.org/10.1016/j.virusres.2011.02.007
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Investigation of hepatitis E outbreak among refugees-Upper Nile, South Sudan, 2012-2013. MMWR Morb Mortal Wkly Rep 2013;62:581-6; PMID:23884344
   PubMed Web of Science ®Google Scholar
• Ahmed JA, Moturi E, Spiegel P, Schilperoord M, Burton W, Kassim NH, Mohamed A, Ochieng M, Nderitu L, Navarro-Colorado C, et al. Hepatitis E outbreak, Dadaab refugee camp, Kenya, 2012. Emerg Infect Dis 2013; 19:1010-2; PMID:23735820; http://dx.doi.org/10.3201/eid1906.130275
   PubMed Web of Science ®Google Scholar
• Gurley ES, Hossain MJ, Paul RC, Sazzad HM, Islam MS, Parveen S, Faruque LI, Husain M, Ara K, Jahan Y, et al. Outbreak of hepatitis E in urban bangladesh resulting in maternal and perinatal mortality. Clin Infect Dis 2014; 59:658-65; PMID:24855146; http://dx.doi.org/10.1093/cid/ciu383
   PubMed Web of Science ®Google Scholar
• Shrestha SM. Hepatitis E in Nepal. Kathmandu Univ Med J 2006;4:530-44; PMID:18603971
   PubMedGoogle Scholar
• Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. Hepatitis E. Lancet 2012; 379:2477-88; PMID:22549046; http://dx.doi.org/10.1016/S0140-6736(11)61849-7
   PubMed Web of Science ®Google Scholar
• Adjei AA, Tettey Y, Aviyase JT, Adu-Gyamfi C, Obed S, Mingle JA, Ayeh-Kumi PF, Adiku TK. Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana. Virol J 2009;6:108; PMID:19619291; http://dx.doi.org/10.1186/1743-422X-6-108
   PubMed Web of Science ®Google Scholar
• Cevrioglu AS, Altindis M, Tanir HM, Aksoy F. Investigation of the incidence of hepatitis E virus among pregnant women in Turkey. J Obstet Gynaecol Res 2004;30:48-52; PMID:14718021; http://dx.doi.org/10.1111/j.1341-8076.2004.00155.x
   PubMed Web of Science ®Google Scholar
• Alvarado-Esquivel C, Sanchez-Anguiano LF, Hernandez-Tinoco J. Hepatitis E virus exposure in pregnant women in rural Durango, Mexico. Ann Hepatol 2014; 13:510-7; PMID:25152983
   PubMed Web of Science ®Google Scholar
• Stoszek SK, Abdel-Hamid M, Saleh DA, El Kafrawy S, Narooz S, Hawash Y, Shebl FM, El Daly M, Said A, Kassem E, et al. High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans R Soc Trop Med Hyg 2006; 100:95-101; PMID:16257426; http://dx.doi.org/10.1016/j.trstmh.2004.12.005
   PubMed Web of Science ®Google Scholar
• Begum N, Devi SG, Husain SA, Kar P. Seroprevalence of subclinical HEV infection in pregnant women from north India: a hospital based study. Indian J Med Res 2009;130:709-13; PMID:20090131
   PubMed Web of Science ®Google Scholar
• Caron M, Kazanji M. Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas. Virol J 2008; 5:158; PMID:19102767; http://dx.doi.org/10.1186/1743-422X-5-158
   PubMed Web of Science ®Google Scholar
• Huang F, Ma T, Li L, Zeng W, Jing S. Low seroprevalence of hepatitis E virus infection in pregnant women in Yunnan, China. Braz J Infect Dis 2013;17:716-7; PMID:24055390; http://dx.doi.org/10.1016/j.bjid.2013.02.006
   PubMed Web of Science ®Google Scholar
• Rostamzadeh Khameneh Z, Sepehrvand N, Khalkhali HR. Seroprevalence of hepatitis E among pregnant women in urmia, iran. Hepat Mon 2013;13:e10931; PMID:24348644; http://dx.doi.org/10.5812/hepatmon.10931
   PubMedGoogle Scholar
• Nelson KE, Shih JW, Zhang J, Zhao Q, Xia N, Ticehurst JR, Labrique AB. Hepatitis E vaccine to prevent morbidity and mortality during epidemics. Open Forum Infect Dis 2014; 1:ofu098; PMID:25734166; http://dx.doi.org/10.1093/ofid/ofu098
   PubMedGoogle Scholar
• Myers ER, Misurski DA, Swamy GK. Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy. Am J Obstet Gynecol 2011; 204:S128-40; PMID:21640230; http://dx.doi.org/10.1016/j.ajog.2011.04.009
   PubMedGoogle Scholar
• Clements KM, Meier G, McGarry LJ, Pruttivarasin N, Misurski DA. Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States. Hum Vaccin Immunother 2014;10:1171-80; PMID:24609063; http://dx.doi.org/10.4161/hv.28221
   PubMed Web of Science ®Google Scholar
• Jia Y, Li L, Cui F, Zhang D, Zhang G, Wang F, Gong X, Zheng H, Wu Z, Miao N, et al. Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China. Hum Vaccin Immunother 2014; 10:2983-91; PMID:25483678; http://dx.doi.org/10.4161/hv.29944
   PubMed Web of Science ®Google Scholar
• Boccalini S, Bechini A, Levi M, Tiscione E, Gasparini R, Bonanni P. Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy. Hum Vaccin Immunother 2013; 9:699-706; PMID:23295824; http://dx.doi.org/10.4161/hv.23268
   PubMed Web of Science ®Google Scholar
• Li SW, Zhang J, Li YM, Ou SH, Huang GY, He ZQ, Ge SX, Xian YL, Pang SQ, Ng MH, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005; 23:2893-901; PMID:15780738; http://dx.doi.org/10.1016/j.vaccine.2004.11.064
   PubMed Web of Science ®Google Scholar
• Kamili S. Toward the development of a hepatitis E vaccine. Virus Res 2011; 161:93-100; PMID:21620908; http://dx.doi.org/10.1016/j.virusres.2011.05.008
   PubMed Web of Science ®Google Scholar
• Cao XY, Ma XZ, Liu YZ. The epidemiology study of ENT-Erically transmitted non-A non-B hepatitis in the South area of Xinjiang, China. Chin J Public Health 1989; 8:193-9; PMID:NOT_FOUND
   PubMedGoogle Scholar
• Xia XZ, Ni YZ, Ai EK, Sai LMJ, Chai P, et al. An epidemiologic survey on a type E hepatitis (HE) outbreak. Chin J Epidemiol 1991; 12:257-60.
   Google Scholar
• Rab MA BM, Mubarik MM, Asghar H, Sami Z, Siddiqi S, et al. Water-borne hepatitis E virus epidemic in Islamabad, Pakistan: a common source outbreak traced to the malfunction of a modern water treatment plant. Tam J Trop Med Hyg 1997; 57:151-7.
   PubMed Web of Science ®Google Scholar
• Jaiswal SP, Jain AK, Naik G, Soni N, Chitnis DS. Viral hepatitis during pregnancy. Int J Gynaecol Obstet 2001;72:103-8; PMID:11166742; http://dx.doi.org/10.1016/S0020-7292(00)00264-2
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hai L, Yin M, Guli N, Ma M. Analysis of 500 cases in pregnant women with HNANB(E). J Xinjiang Med Univ 1990;13:54-8; PMID:NOT_FOUND
   PubMedGoogle Scholar
• Jain AK JS, Jhamad S, Soni N, Sircar S, Jain M. To find out maternal and foetal outcome in pregnant women infected with acute viral hepatitis E(AVH-E) during third trimeter of pregnancy- a retrospective analysis. J Hepatol 2013;58:S500; PMID:NOT_FOUND; http://dx.doi.org/10.1016/S0168-8278(13)61234-9
   PubMedGoogle Scholar
• Hamid SS, Jafri SM, Khan H, Shah H, Abbas Z, Fields H. Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis? J Hepatol 1996;25:20-7; PMID:8836897; http://dx.doi.org/10.1016/S0168-8278(96)80323-0
   PubMed Web of Science ®Google Scholar
• Banait VS, Sandur V, Parikh F, Murugesh M, Ranka P, Ramesh VS, Sasidharan M, Sattar A, Kamat S, Dalal A, et al. Outcome of acute liver failure due to acute hepatitis E in pregnant women. Indian J Gastroenterol 2007; 26:6-10; PMID:17401226
   PubMedGoogle Scholar
• Bose PD, Das BC, Hazam RK, Kumar A, Medhi S, Kar P. Evidence of extrahepatic replication of hepatitis E virus in human placenta. J Gen Virol 2014; 95:1266-71; PMID:24622580; http://dx.doi.org/10.1099/vir.0.063602-0
   PubMed Web of Science ®Google Scholar
• Kumar A, Devi SG, Kar P, Agarwal S, Husain SA, Gupta RK, Sharma S. Association of cytokines in hepatitis E with pregnancy outcome. Cytokine 2014; 65:95-104; PMID:24416783; http://dx.doi.org/10.1016/j.cyto.2013.09.022
   PubMed Web of Science ®Google Scholar
• Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007; 147:28-33; PMID:17606958; http://dx.doi.org/10.7326/0003-4819-147-1-200707030-00005
   PubMed Web of Science ®Google Scholar
• Xiu SX. Disease Burden of Hepatitis E and Health Economic Evaluation of Vaccine Interventions in Dongtai Area. Southeast Univ 2011.
   Google Scholar
• Rein DB, Hicks KA, Wirth KE, Billah K, Finelli L, Fiore AE, Hoerger TJ, Bell BP, Armstrong GL. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Pediatrics 2007; 119:e12-21; PMID:17200237; http://dx.doi.org/10.1542/peds.2006-1573
   PubMed Web of Science ®Google Scholar
• Xiu SX, Zhang XF, Jiang HM, Yang CL, Wang ZZ, Huang SJ, et al. Disease burden of hepatitis E in rural areas in east China. Chin J Zoonoses. 2011; 27:450-4.
   Google Scholar
• Peasah SK, Azziz-Baumgartner E, Breese J, Meltzer MI, Widdowson MA. Influenza cost and cost-effectiveness studies globally-a review. Vaccine 2013; 31:5339-48; PMID:24055351; http://dx.doi.org/10.1016/j.vaccine.2013.09.013
   PubMed Web of Science ®Google Scholar
• http://www.who.int/csr/disease/hepatitis/whocdscsredc200112/en/index3.html.
   Google Scholar
• Echevarria JM. Light and Darkness: Prevalence of Hepatitis E Virus Infection among the General Population. Scientifica 2014; 2014:481016; PMID:24672733; http://dx.doi.org/10.1155/2014/481016
   PubMedGoogle Scholar
• Das A, Sinha M. A cost-effectiveness analysis of a candidate vaccine against hepatitis E virus using the institute of medicine model. Am J Gastroenterol 2001;96:S263; PMID:NOT_FOUND
   PubMed Web of Science ®Google Scholar
• Riedmann EM. Chinese biotech partnership brings first hepatitis E vaccine to the market. Hum Vaccin Immunother 2012;8:1743-4; PMID:AMBIGUOUS
   PubMed Web of Science ®Google Scholar
• Lee BY, Wateska AR, Bailey RR, Tai JH, Bacon KM, Smith KJ. Forecasting the economic value of an Enterovirus 71 (EV71) vaccine. Vaccine 2010; 28:7731-6; PMID:20923711; http://dx.doi.org/10.1016/j.vaccine.2010.09.065
   PubMed Web of Science ®Google Scholar
• Zhuang GH, Pan XJ, Wang XL. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China. Vaccine 2008; 26:4608-16; PMID:18597903; http://dx.doi.org/10.1016/j.vaccine.2008.05.086
   PubMed Web of Science ®Google Scholar
• Berge JJ, Drennan DP, Jacobs RJ, Jakins A, Meyerhoff AS, Stubblefield W, Weinberg M. The cost of hepatitis A infections in American adolescents and adults in 1997. Hepatology 2000; 31:469-73; PMID:10655272; http://dx.doi.org/10.1002/hep.510310229
   PubMed Web of Science ®Google Scholar
• Karam V, Castaing D, Danet C, Delvart V, Gasquet I, Adam R, Azoulay D, Samuel D, Bismuth H. Longitudinal prospective evaluation of quality of life in adult patients before and one year after liver transplantation. Liver Transpl 2003;9:703-11; PMID:12827557; http://dx.doi.org/10.1053/jlts.2003.50148
   PubMed Web of Science ®Google Scholar